Second Covid-19 trial paused within 24 hours over safety concerns

Two late-stage Covid-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against the pandemic. ​​​US pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients over an unspecified incident.

from US News Headlines, Latest USA News, US Election 2020 news on Times of India https://ift.tt/3lHjE24